IFA
Invus Financial Advisors Portfolio holdings
AUM
$89.2M
This Quarter Return
+17.69%
1 Year Return
-10.79%
3 Year Return
-29.46%
5 Year Return
–
10 Year Return
–
AUM
$197M
AUM Growth
–
Cap. Flow
+$197M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
$63.3M |
| 2 |
Yext
YEXT
|
$59.8M |
| 3 |
NovoCure
NVCR
|
$39.7M |
| 4 |
Arcus Biosciences
RCUS
|
$18.6M |
| 5 |
UBX
Unity Biotechnology
UBX
|
$15.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 69.67% |
| 2 | Technology | 30.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
1
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $63.3M | 32.1% |
+2,590,015
| New | +$63.3M |
|
|
2
Yext
YEXT
$1.11B
| $59.8M | 30.33% |
+4,146,784
| New | +$59.8M |
|
|
3
NovoCure
NVCR
$1.38B
| $39.7M | 20.13% |
+470,884
| New | +$39.7M |
|
|
4
Arcus Biosciences
RCUS
$1.13B
| $18.6M | 9.44% |
+1,842,077
| New | +$18.6M |
|
|
UBX
5
DELISTED
Unity Biotechnology
UBX
| $15.8M | 8.01% |
+2,189,998
| New | +$15.8M |
|